Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
Clinical trial NCT03363854 · COMPLETED
Trial details
- NCT number
- NCT03363854
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2019-03-08
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.